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Abstract
Neutrophil extracellular traps (NETs) consist of antimicrobial molecules embedded in a web of extracellular DNA.
Formation of NETs is considered to be a defense mechanism utilized by neutrophils to ensnare and kill invading
pathogens, and has been recently termed NETosis. Neutrophils can be stimulated to undergo NETosis ex vivo, and
are predicted to contain high levels of serine proteases, such as neutrophil elastase (NE), cathepsin G (CG) and
proteinase 3 (PR3). Serine proteases are important effectors of neutrophil-mediated immunity, which function directly
by degrading pathogenic virulent factors and indirectly via proteolytic activation or deactivation of cytokines,
chemokines and receptors. In this study, we utilized a diverse and unbiased peptide library to detect and profile
protease activity associated with NETs induced by phorbol-12-myristate-13-acetate (PMA). We obtained a
“proteolytic signature” from NETs derived from healthy donor neutrophils and used proteomics to assist in the
identification of the source of this proteolytic activity. In addition, we profiled each neutrophil serine protease and
included the newly identified enzyme, neutrophil serine protease 4 (NSP4). Each enzyme had overlapping yet distinct
endopeptidase activities and often cleaved at unique sites within the same peptide substrate. The dominant
proteolytic activity in NETs was attributed to NE; however, cleavage sites corresponding to CG and PR3 activity were
evident. When NE was immunodepleted, the remaining activity was attributed to CG and to a lesser extent PR3 and
NSP4. Our results suggest that blocking NE activity would abrogate the major protease activity associated with
NETs. In addition, the newly identified substrate specificity signatures will guide the design of more specific probes
and inhibitors that target NET-associated proteases.
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Introduction
Neutrophils are the most abundant leukocytes in plasma.
They are the first cells recruited to injury sites in response to
pathogen invasion, and they act as the first line of innate
immune defense. Neutrophils have traditionally been
considered effector cells for the inflammatory response and
acute immunity, functioning through intracellular phagocytosis,
and using lytic proteases, reactive oxygen species and
microbicidal proteins to attack infective agents. Recent studies
have shown that neutrophils also have the capacity to regulate
the immune response by expressing cytokines, chemokines, Fc
receptors and complement components for signaling with other
immune cells, such as dendritic cells, B cells and T cells [1].
Proteases are important effectors of neutrophils. They not
only contribute directly to microbicidal activity but also function
in the proteolytic processing of chemokines, cytokines and
receptors [2,3]. This modulatory activity is exemplified by the
caspase-independent activation of IL-1β and IL-18 by NE, PR3
and CG [4,5,6] or the conversion of anti-inflammatory
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progranulin to pro-inflammatory granulin by NE and PR3 [7].
Furthermore, NE has been shown to couple neutrophil-
mediated inflammation with the coagulation pathway by
cleaving tissue factor pathway inhibitor on Neutrophil
Extracellular Traps (NETs).
NETs are released by stimulated neutrophils in a specific
form of cell death called NETosis. NETosis is hypothesized to
represent a new mechanism of innate immunity mediated by
neutrophils in response to pathogen invasion [8,9]. It is
characterized by the formation of NETs, networks made of
decondensed chromatin and anti-microbial proteins and
peptides. NETosis represents a new paradigm of cell death
that is distinct from apoptosis and necrosis in many aspects.
No nuclear fragmentation or membrane blebbing is observed,
and activation is independent of caspase activity, although
NADPH oxidase is required [10]. NETosis also involves
activities of NE and myeloperoxidase [11], histone citrullination
by peptidylarginine deiminase 4 [12] and activation of the Raf-
MEK-ERK pathway [13]. It has been hypothesized that the
primary function of NETs is to trap and kill pathogens. In
addition, it also provides a matrix for establishing high local
concentrations of effectors and mediators for the ensuing
innate and adaptive immune responses.
Stimulation of neutrophils with PMA causes the release of
each of the serine proteases NE, PR, CG [14] and NSP4 [15]
and the metalloproteases, MMP-8 and MMP-9 [16]. However,
only NE, PR and CG have been found to be associated with
the resulting NET [14]. To characterize NET-associated
proteolytic activities in an unbiased manner, proteins trapped in
NETs were released and assayed with the Multiplex Substrate
Profiling by Mass Spectrometry (MSP-MS) method [17]. This
method utilizes a library of 124 highly diversified peptides in a
multiplex assay with tandem liquid chromatography-mass
spectrometry for detection of cleavage sites. Using the MSP-
MS assay, a proteolytic signature was uncovered for each
donor sample and compared to the signatures generated for
each neutrophil serine protease. By deconvolution of the NETs’
associated protease activities we determined that the major
activity was attributed to NE. Immunodepletion of NE activity
revealed important contributions from PR3 and to a lesser
extent CG and NSP4. Identifying the substrate specificity and
the contribution of each NET-associated protease to overall
NET-associated activity could lead to the development of
therapeutics to alleviate pathological NETosis in acute and
chronic immune diseases.
Results
Induction of NETs with enriched protease activity
NE, PR3 and CG were previously identified in NETs and
together were estimated to make up ~9% of the total protein
associated with the NETs [14]. To estimate proteolytic activity
in PMA-induced NETs generated from healthy donor
neutrophils we screened a set of internally quenched
fluorescent peptides and identified a substrate that was readily
cleaved by all three enzymes (Figure 1A, Figure S1). This
substrate, K(Mca)-PLGKQVEY-K(Dnp), was previously used to
assay a glutamic acid protease secreted from a fungus [18].
Using this probe, the proteolytic activity released from NETs
derived from PMA and Micrococcal Nuclease (MNase) treated
neutrophils ranged from 0.047 to 0.068 µmoles/min/mg. For
individual donors this activity was approximately five-fold
greater than control samples that lack PMA treatment, and
twenty- to forty-fold greater than control samples that lacked
MNase treatment (Figure 1B). These assays confirmed that
activated neutrophils produce NETs that are enriched with
proteases that can be released upon nuclease treatment.
Comparison of substrate signatures of NET associated
proteases from donor neutrophils
We employed MSP-MS to generate a substrate signature of
proteases associated with NETs from PMA activated
neutrophils and compared the substrate specificity for each
donor sample (Figure 2A-C). Each donor sample contained
proteases with a distinct preference for isoleucine, valine and
threonine in the P1 position while arginine, glutamine and
tryptophan were significantly enriched (p ≤ 0.05) at P4, P3 and
P2′ positions, respectively. Furthermore, cleavage was rarely
observed on the C-terminal side of amino acids with charged
side chains with the exception of lysine, while proline is not well
tolerated in either the S3, S1 or S1′ pockets of these proteases.
When donors were directly compared, 40 shared cleavage
sites were identified and each donor sample had between 7
and 11 unique cleaved bonds (Figure 2D). When the location of
each cleavage site was analyzed, no hydrolysis was evident
near the N-termini of the tetradecapeptides, indicating that
these neutrophil derived enzymes lacked aminopeptidase
specificity (Figure 2E). However, cleavage readily occurred
near the C-termini, indicating the presence of
carboxypeptidases or endoproteases that have little specificity
at the non-prime side of the scissile bond.
Identification of NET associated proteins
To identify the full complement of proteins embedded in the
NETs, protein preparations from the same NETosis-induced
neutrophils described above were subjected to proteomic
analysis to evaluate the protein composition of neutrophils after
PMA and MNase treatment (Table 1). Using mass
spectrometry, 29 proteins were identified in PMA- and MNase-
treated neutrophil samples, however only NE, alpha-enolase
and Histones H2A and H3 were found to be specifically
enriched relative to the control samples. Eleven proteins were
reproducibly identified in all three PMA- and MNase-treated
donor samples, which included NE and the inactive serine
protease family member, azurocidin. Surprisingly, while our
enzymatic studies indicated an enrichment of proteolytic
activity in NETs from PMA- and MNase-treated neutrophils
relative to the control samples, there was little or no enrichment
of proteases in the same samples when analyzed by mass
spectrometry-based proteomics. CG was found in one donor
sample while PR3, NSP4 and MMP-8 were never observed.
Two peptides corresponding to MMP-9 were observed in a
MNase only treated sample.
Substrate Signature of NETs Associated Proteases
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MSP-MS profiling of NE and comparison to NETs
Based on our proteomic data, the majority of proteolytic
activity in NETs was predicted to be derived from NE. To test
this prediction, the substrate specificity of purified NE was
profiled using both MSP-MS and the more established
positional scanning synthetic combinatorial library (PS-SCL)
assay [19]. This enzyme was isolated from human neutrophils
and was found to be free of other neutrophil or serum
proteases using mass spectrometry based proteomic analysis
(data not shown). In the PS-SCL assay the P1 site of NE had a
distinct preference for valine, alanine, threonine and isoleucine.
In addition, proline was preferred in P2, glutamine, glutamic
acid and methionine in P3 and norleucine in P4 (Figure 3A).
Using the MSP-MS assay, NE had a preference for isoleucine,
valine and threonine in the P1 position and had low tolerance
for asparagine, lysine and most other amino acids with charged
side chains. In addition arginine, glutamine, norleucine and
tryptophan were significantly enriched (p ≤ 0.05) at the P4, P3,
P1’ and P2′ positions, respectively. A Pearson correlation was
performed on the NE profiles from the MSP-MS and PS-SCL
methods which showed that each non-prime subsite had strong
positive correlation with a score of ≥0.4 on a scale from -1.0 to
1.0 (Table 2). This validated the MSP-MS assay as a method
for profiling the substrate specificity of NE and other serine
neutrophil serine proteases.
To generate a representative “donor signature”, the 40
cleavages observed in all three donor samples were
aggregated into a single motif. An advantage of using the MSP-
MS assay over the PS-SCL assay for profiling biological
samples is that specific cleavage of peptide substrates can be
directly linked to a protease. The cleavage sites that were
common to all three donors were directly compared with the
substrate profile of purified NE (Figure 3C) and correlated
strongly between P4 and P3′ (Table 2). In addition we
determined that 33 of the cleaved bonds that occur in donor
samples could also be hydrolyzed by NE (Figure 3C) which
provided evidence that the major proteolytic activity in NETs is
derived from NE. However, seven of the cleavage sites could
not be directly linked to NE activity, therefore additional
proteases were active on NETs.
MSP-MS profiling of CG, PR3 and NSP4 and
comparison to NETs
CG, PR3 and the newly identified neutrophil serine proteases
NSP4 have been shown to be released from PMA activated
neutrophils [14,15], therefore these enzymes were profiled
Figure 1.  Monitoring of proteolytic activity in neutrophil extracellular traps.  A. Identification of an internally quenched
fluorescent substrate that is hydrolyzed by NE, CG and PR3. B. Extracellular proteolytic activity was analyzed from 3 donor
neutrophils (Donor 1, dark grey; Donor 2, black; Donor 3, light grey) following treatment with PMA, MNase or a combination of both.
Proteolytic activity was measured using (K-Amc) PLGKQVEY(K-Dnp).
doi: 10.1371/journal.pone.0075141.g001
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using MSP-MS to identify the source of the unknown proteolytic
activity in NETs. In the P1 positions, PR3 had approximately
equal preference for alanine, valine, threonine and isoleucine,
CG favored phenylalanine over tyrosine and lysine, while NSP4
had a strict preference for arginine (Figure 4A-C). Outside of
the P1 subsite, PR3 showed selectivity for aspartic acid and
asparagine at P2, and norleucine, leucine and glycine at P4,
P3 and P2′, respectively while CG had a preference for
norleucine at P2. In contrast to the other neutrophil serine
proteases, NSP4 specificity was so selective for P1 arginine
residues that only 19 bonds were cleaved in the library after 20
hours incubation. In order to further characterize non-prime
side specificity, each enzyme was assayed using the PS-SCL
method and the P4 to P1 site preferences were identified
(Figure S2).
Using the MSP-MS datasets, a Venn diagram was generated
to highlight the unique and shared cleavage sites for each of
the neutrophil serine proteases. Interestingly, for a family of
enzymes that share high sequence identity, they have each
evolved to cleave a defined set of unique peptide bonds. When
compared to the unknown cleavage sites in NETs, we
determined that 5 of the 7 sites were matched to CG while one
site was matched to PR3 activity. With the knowledge that CG
and PR3 are active in NETs we were now only able to directly
assign 18 of the cleavage sites to NE as many of the sites can
be cleaved by more than one neutrophil serine protease
(Figure 4E). A single unidentified cleavage site occurred
between valine and isoleucine in a peptide containing the
sequence PHWQRVIFFRLNTP. Although not observed in the
individual enzyme assays, cleavage at this P1 valine site is
likely to be the result of NE, CG or both.
Immunodepletion of NE from NETs
In order to confirm that NE was the major proteolytic activity
in NETs, we selectively removed the enzyme by
immunodepletion, and assayed the remaining proteases in the
mixture. On this occasion, we were able to increase the total
amount of NE-depleted donor protein in the assay by 15-fold,
which resulted in only a 1.7 to 2.3-fold increase in the number
of cleavage bonds identified in each donor sample (Figure S3).
The NE-depleted donor samples shared 76 cleavage sites and
12 to 16 unique cleaved bonds were identified for each donor
(Figure 5). The substrate signature of the shared cleavage
sites showed a preference for phenylalanine, arginine and
lysine in the P1 position, while arginine and norleucine were
most often found in P3 and P2 sites, respectively. When
compared to the individual serine protease datasets, we
Figure 2.  Determination of the proteolytic signatures in NETs.  A-C. IceLogos representing the P4 to P4′ sites for NETs
isolated from three donor samples. Amino acids that are most frequently observed (above axis) and least frequently observed
(below axis) are illustrated. The number of cleavage sites used to make each iceLogo are listed in the bottom right-hand corner.
Residues that are highlighted in black text are significantly (p = 0.05) enriched relative to the frequency that these same amino acids
are found in the peptide library (5.2 +/- 0.5%). The amino acid ‘n’ corresponds to norleucine. D. Determination of the number of
cleavage sites that are common and unique to each donor sample. E. Positional frequency of all donor-derived cleavage sites within
the tetradecapeptides (n=85).
doi: 10.1371/journal.pone.0075141.g002
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B4E335 43 17.33 (1) 97 173 73 141 39226.3 Actin, beta
P05164 99 97.33 (3) 27 43 35 47 83869.4 Myeloperoxidase
A8K9U8 71 41.67 (2) 80 128 43 65 78338.9 Lactoferrin
P08246 59 68.33 (3) - - 36 64 28518.3 Neutrophil elastase
B4DLA9 43 42 (1) 14 24 21 47 14841.5 Histone H2B
B2R4P9 43 54.33 (3) - - - - 15328 Histone H3
A3KPC7 38 39.33 (2) - - - - 13906.4 Histone H2A
P20160 33 32.67 (3) 10 13 12 13 26885.9 Azurocidin
B2R4R0 30 51 (3) 8 9 20 41 11367.4 Histone H4
P35579 - - 23 30   226534.2 Myosin-9
B3KSI4 8 2.67 (1) 8 11 24 31 58982.1 Transketolase-like
P06733 14 7.33 (3) - - 20 32 47169.4 Alpha-enolase
A3R0T8 11 7 (3) 18 25 7 12 21865.4 Histone 1, H1e
B2R4C5 17 6.33 (1) 21 23 18 23 16537.2 Lysozyme
P08311 15 6 (1) 14 20 10 13 28837.5 Cathepsin G
B2R4M6 3 1 (1) 14 24 16 28 13210.1 Protein S100-A9
P59665 14 25 (3) 16 59 13 37 10201.1 Neutrophil defensin 1
A4UCT1 10 4.67 (3) 11 13 14 20 17303.1 Glyceraldehyde-3-Pdehydrogenase
B2R829 - - 20 27 - - 45850.5 MNDA-like
A2A418 4 1.33 (2) 13 14 13 17 80641.3 Gelsolin
C5HZ13 - - - - 12 21 16453 Charcot-Leyden crystal protein
B4DE36 2 1 (2) - - 8 10 60186.3 Glucose-6-phosphate isomerase
P07737 3 3 (2) 3 3 7 10 15054.4 Profilin-1
P31146 5 1.67 (1) - - 11 22 51026.7 Coronin-1A
A8K4W6 - - 7 8 9 11 44615.1 Phosphoglycerate kinase
B4DNK4 - - 6 7 - - 49898.2 Pyruvate kinase
P80723 - - 6 6 3 3 22693.6 Brain acid soluble protein 1
B0YJC4 - - - - 10 16 49653.8 Vimentin
B4E112 - - 3 6 4 7 12459.7 Cofilin-1-like
A2VCK8 4 4 (2) 8 25 5 22 5052.7 Thymosin beta 4, X-linked
P12724 - - 6 7 - - 18385.5 Eosinophil cationic protein
P05109 5 2.67 (3) 3 5 7 9 10834.6 Protein S100-A8
A8K220 - - 3 4 4 7 18012.7 Peptidyl-prolyl cis-trans isomerase
A8MX94 - - - - 3 3 19480.7 Glutathione S-transferase P
F2Z393 1 0.33 (1) - - 4 4 35329.2 Transaldolase
B4DJI2 - - 4 6 1 2 56853.5 Granulins-like
A8K2Y9 - - - - 5 6 53140.5 6-P gluconate dehydrogenase
P49913 - - 4 4 - - 19301.6 Cathelicidin antimicrobial peptide
O60234 1 0.33 (1) 3 3 - - 16801.5 Glia maturation factor gamma
D6R9A6 1 0.67 (1) 6 14 - - 15403.9 High mobility group box 2
A8K2L4 - - 3 4 1 1 37247.9 LSP1-like
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determined that 36 of the 76 cleavage sites were attributable to
CG activity. In addition, PR3 and NSP4 accounted for 7 and 1
cleaved bonds, respectively, while the protease(s) responsible
for 15 cleavage sites could not be determined. The successful
depletion of NE was evident by the presence of a single NE


















P80511 2 1 (1) - - - - 10575.1 Protein S100-A12
B3KUI1 1 1.33 (3) 3 4 3 4 25043.3 Plastin-2-like
B5BU38 - - - - 3 4 38680.6 Annexin
A7XZE4 - - 2 3 3 3 33026.2 Beta tropomyosin isoform
Q5T123 3 1.67(2) 2 3 - - 9380.6 SH3BGRL3
P05204 - - 3 8 2 11 9392.7 HMGN2
B0QZK8 - - 2 2 - - 13683.9 HP1BP3
B7Z507 - - - - 2 2 71554.8 MMP9-like
Q68D08 - - - - 2 2 36750.3 DKFZp686B04128
The number of unique peptide counts corresponds to the total number of unique peptide sequences that identify a protein entry. The peptide count is the number of peptide
spectra observations for a given protein, either reported as the mean across three replicate experiments or individually for the control experiments.
doi: 10.1371/journal.pone.0075141.t001
Figure 3.  Substrate specificity profiling of human Neutrophil Elastase A.  Positional scanning of the P4 to P1 subsites of NE
using the PS-SCL assay. B An iceLogo illustrating amino acids that are most frequently (above axis) and least frequently (below
axis) observed in the P4 to P4′ sites of NE. Residues that are highlighted in black are significantly (p = 0.05) enriched or de-enriched
in the subsites relative to the frequency that these same amino acids are found in the peptide library (5.2 +/- 0.5%). C. A
representative “donor signature” consisting of 40 cleavage sites that are common to the three donors. D. A pie chart representing
the 40 cleavage sites that are common to the donor samples. 33 of these sites are also hydrolyzed by NE.
doi: 10.1371/journal.pone.0075141.g003
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is due to an unidentified low abundance protease with
overlapping specificity. In addition, hydrolysis of the
PHWQRVIFFRLNTP peptide at the V-I site was not evident in
the NE-depleted samples indicating that the cleavage site was
the product of NE activity.
Taken together, we have utilized a novel substrate based
profiling method to determine that NE and to a lesser extent
CG and PR3 are active in neutrophil derived NETs. In addition,
by selectively removing NE we have been able to perform an
in-depth characterization of less abundant proteolytic activity
Table 2. Comparison of NE substrate specificity using
MSP-MS with NET Donors and NE using PS-SCL.
 P4 P3 P3 P1 P1′ P2′ P3′ P4′
NE (PS-SCL) 0.50 0.82 0.41 0.65 - - - -
Donors 0.63 0.85 0.70 0.95 0.69 0.79 0.58 0.34
Pearson correlation values of <0.4 indicate weak or no correlation while values
≥0.4 and ≥0.7 represent strong and very strong correlation, respectively.
doi: 10.1371/journal.pone.0075141.t002
and determined that NSP4 and at least one other protease are
also active in NETs.
Discussion
The formation of neutrophil extracellular traps is a novel host
defense strategy in addition to the well characterized
phagocytosis of neutrophils. Many groups have shown that
viruses [20], bacteria [8] and fungi [21,22] stimulate neutrophils
to release extracellular DNA, although it has been suggested
that this process is an incidental component of neutrophil lysis
or a hijacking of host pathways by the pathogen [23]. However,
there is increasing evidence that NETosis is a highly
orchestrated mechanism of cellular defense and is under tight
control [24]. Irrespective of the mechanism by which chromatin
and other cytotoxic components are released from neutrophils
and assembled into NETs, the resultant damage to host tissue
has been shown to promote inflammatory diseases such as
cystic fibrosis [25], asthma [26], systemic vasculitis [7],
systemic lupus erythematosus [27,28] and other acute and
chronic diseases [9,29]. In unstimulated neutrophils, a set of
homologous serine proteases are stored in azurophilic
Figure 4.  Determination of proteolytic signature of PR3, CG and NSP4.  A-C. IceLogos representing the P4 to P4′ sites for
PR3, CG and NSP4. Amino acids that are most frequently observed (above axis) and least frequently observed (below axis) are
illustrated. The number of cleavage sites used to make each iceLogo are listed in the bottom right-hand corner. Residues that are
highlighted in black text are significantly (p ≤ 0.05) enriched relative to the frequency that these same amino acids are found in the
peptide library (5.2 +/- 0.5%). The amino acid ‘n’ corresponds to norleucine. D. A 4-way venn diagram illustrating the number of
unique and overlapping peptide bonds that are cleaved by each neutrophil serine protease. E. A pie chart representing the 40
cleavage sites that are common to the donor samples. ‘Shared’ corresponds to cleavage sites that are derived from more than one
neutrophil serine protease.
doi: 10.1371/journal.pone.0075141.g004
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granules and their enzymatic activities are subject to
intracellular compartmentalization and endogenous inhibitors
[30]. Upon stimulation with PMA or bacteria they are released
and selectively associated with extracellular DNA [14,31]. As
extracellular proteins, the activity of these enzymes may no
longer be under the control of inhibitors and, therefore,
unregulated proteolysis could be initiated and prolong an
inflammatory response [32]. Alternatively, association of these
proteases with NETs could provide a means to
compartmentalize and minimize their destructive proteolytic
activities. It is worth noting that serine proteases seem to be
selectively targeted to NETs since caspases that are important
components of inflammasomes, and matrix metalloproteases
were not detected on NETs. One simple explanation is that NE,
CG and PR3 are positively charged basic proteins which have
high affinity to the negatively charged DNA. Previous studies
by Dubois and colleagues have used highly selective
fluorescent substrates of NE, PR3 and CG to assess the
proteolytic activity in NETs from Cystic Fibrosis sputum and
from neutrophils stimulated with S. aureus and P. aeruginosa
[25]. DNase treatment of sputum dramatically increased its NE
activity, but not the activities of CG and PR3. They also
determined that nuclease treatment of extracellular DNA from
stimulated neutrophils caused a ~2.5 fold increase in soluble
proteolytic activity relative to unstimulated cells, and that the
contribution of each enzyme to the overall activity was
approximately 40% for NE, 40% for PR3 and 20% for CG.
Their study demonstrated that NETs are enriched in serine
proteases and NE and PR3 are main contributors to NETs
associated proteolytic activity.
In our study, we utilized a highly sensitive and unbiased
substrate profiling method to characterize the entire proteolytic
signature associated with NETs. MSP-MS is an ideal
technology to profile complex biological samples because the
substrate population consists of a defined set of peptides and,
therefore, cleavage sites can be directly linked to a specific
enzyme. Furthermore, the unbiased design of the peptides and
combination into equimolar pools ensures that proteolytic
activity from multiple proteases can be monitored
simultaneously without prior knowledge of the substrate
specificity. The reproducibility of both the sample preparation
and the MSP-MS assay was evident as many of the peptides
cleaved in three independent donor samples in this study were
identical. Any variation between donors could be due to
differences in genetic background, or immune status of each
individual. Inter-individual variability has recently been
highlighted by Barrientos and coworkers, where NET-
associated proteolytic activity between donors differed by as
much as 9-fold [33].
In our study, all of the proteolytic activity released from PMA-
activated neutrophils could be attributed to NE, CG and PR3
activity. However, ~70% of cleavage sites were likely to be the
result of NE activity and CG and PR3 contributed to the
remaining 25% and 5%, respectively. As expected, when NE
was immunodepleted from the NET extracts, CG became the
dominant source of proteolytic activity. The remaining
proteolytic activity was likely to be the product of PR3 and to a
lesser extent NSP4 and other as yet unidentified NET
associated proteases. Interestingly, PMA stimulation of
neutrophils resulted in PR3 activity that was considerably lower
than CG while other studies using bacterial stimulated
neutrophils show the reverse. These data indicate that
protease composition in NETs may differ depending on the
type of stimulation. Khandpur and coworkers analyzed the
composition in NETs following alternate stimulation and found
differences in both the protein levels and protein composition
[33,34].
Proteomic analysis was used to identify proteins released
from the NETs, many of which have been observed in a
previous study [14]. Interestingly, we found that NE is tightly
bound to DNA and was not found in samples that lacked
nuclease treatment. CG was found in all samples independent
of treatment regimes while PR3 and NSP4 were not detected.
Since robust PR3 activity was evident in the MSP-MS assay
these data indicate that a functional activity assay has superior
Figure 5.  Determination of the proteolytic signatures in NE-depleted NETs.  A. After immunodepletion of NE from donor NET
samples, the MSP-MS assay was performed at 15-fold higher total protein concentration. A total of 153 cleaved bonds were
identified in the 3 donor samples and 76 cleaved bonds were common to each donor. B. An iceLogo illustrating the proteolytic
signature of cleavage sites that are common to each NE-depleted donor. C. A pie chart representing the 76 cleavage sites that are
common to the donor samples. ‘Shared’ corresponds to cleavage sites that are derived from more than one neutrophil serine
protease.
doi: 10.1371/journal.pone.0075141.g005
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sensitivity than proteomic based methods for detecting
proteases.
Previously, Proteomic Identification of Protease Cleavage
Sites (PICS) was utilized to generate extended substrate
specificity profiles of NE, CG and NSP4 [15,35]. In these
studies, proteome derived peptides were used as the substrate
library and cleavage by the neutrophil serine proteases was
monitored by mass spectrometry. As was observed for the PS-
SCL method, the substrate profiles using PICS strongly
correlated with our MSP-MS data (Table S1). However, our
study is the first to directly compare the substrate specificity of
all four homologous neutrophil serine proteases under identical
assay and instrumentation conditions, and reveals distinct
cleavage sites that are uniquely cut by each enzyme.
Traditionally, the neutrophil serine proteases were considered
to have redundant functionalities based on their ability to
hydrolyze structural proteins such as collagen, laminin,
fibronectin and elastin [30]. However, out of the 180 bonds that
were hydrolyzed by the four proteases only 28 cleavage sites
were shared between two or more enzymes. Therefore,
although our substrate profiling was performed using a
synthetic peptide library, it is likely that many in vivo protein
substrate cleavage sites exist that are unique to each
neutrophil protease.
Successful substrate prediction tools require an
experimentally determined list of protein or peptide substrates
to identify sequence and structural features important for
protease recognition. The predictive power for identifying
natural substrates can be improved by incorporating negative
substrates. Using the MSP-MS assay, any peptide bond that is
cleaved by a neutrophil serine protease is a true substrate
while every bond that is not cleaved is considered a true
negative substrate. Using data generated in this study it may
be possible to identify and track endogenous substrates of
these proteases during neutrophil lysis and/or NET formation
which will provide us with a greater understanding of roles of
these enzymes in immune response and inflammation.
In this study, it is evident that targeting of NE on NETs could
minimize adverse effects of unregulated proteolysis associated
with tissue damage and inflammation. The selective cleavage
sequences of the neutrophil serine proteases identified in this
study will be valuable for designing substrates, inhibitors,
activity based imaging agents [36] and protease-activated
prodrugs [37]. In addition, the substrate signature of NETs-
associated protease activity can be monitored as a biomarker




All data were analyzed anonymously and all aspects of this
study were conducted according to the principles expressed in
the Declaration of Helsinki. Human subject research approval
for this study was received from the Western Institutional
Review Board (study No: 1084207). All participants provided
written informed consent prior to the start of the study.
Isolation of neutrophils from healthy donors
Human neutrophil cells were isolated by a two-step
purification protocol using Red Blood Cell (RBC) sedimentation
followed by removal of monocytes using Ficoll density gradient
centrifugation. Briefly, 50 ml of fresh human whole blood was
collected in a collection tube containing heparin. Blood was
mixed with HetaSep (STEM cell, Cat# 07906) at the ratio (5:1)
to precipitate RBCs and platelets. Supernatants with enriched
leukocytes and monocytes were layered on top of Ficoll-
PAQUE PLUS (GE Healthcare, Cat# 17-1440-03). After Ficoll
gradient centrifugation, neutrophils were separated from
monocytes in the supernatant and pelleted. Contaminating
RBCs were further removed by repeated cell lysis using RBC
lysis buffer (Miltenyi Biotec, Cat# 130-094-183). By this method,
50-100 million neutrophils were isolated to greater than 98%
purity, as confirmed by flow cytometry using CD66b antibodies
(BD Pharmamingen, Cat# 555724).
NETosis induction and NET preparation
Purified neutrophils were washed five times to remove
plasma proteins, then seeded at a density of 1.7 x 106 cells/ml
in RPMI 1640 media supplemented with glutamine in a 10 mm
culture plate. NETosis was induced in vitro by stimulating
neutrophils with 50 nM phorbol-12-myristate-13-acetate (PMA,
Sigma P8139) at 37°C in a 5% CO2 incubator. After induction
for 3 hours, media was removed and plates were washed
gently with warm media for three times. The induction time was
selected for maximum protein release from NETs after PMA
treatment. NETs were then digested by Micrococcal Nuclease
(MNase) (20 U/ml) (Thermo Scientific, Cat# 88216) for 10-40
minutes and released into media. The supernatant was
subsequently centrifuged to remove cells and cellular debris.
Supernatants from PMA-untreated neutrophils and PMA-
treated neutrophils but without MNase digestion were prepared
as negative controls. A fraction of each sample was treated
with protease inhibitor cocktail to preserve the sample for
proteomic analysis, whereas the remainder of the sample for
protease activity screening was not treated with protease
inhibitors. Progression of NETosis was monitored by
measuring cell-free DNA using Sytox Orange (Life
Technologies, S11368). DNA was quantified by relative
fluorescence measurement with a SpectraMax M2 fluorometer
(Molecular Devices) at a filter setting of 544 nm (ex)/ 590 nm
(em) and calibrated by standard curve with DNA standard of
known concentration. NETosis was also visually examined by
confocal immunofluorescent microscopy. Neutrophils (5 x 105
cells/ml) were seeded on poly-L-lysine coated cover slips and
treated with or without 50 nM PMA. At different time points
post-NETosis induction, cells were fixed with 4%
paraformaldehyde, then permeablized and blocked with 10%
FBS in phosphate buffered saline (PBS) with 0.05% Triton
X-100. For histone staining, coverslips were incubated with a
mouse anti-human core histone antibody (Millipore, Anti-
histone Clone H11-4, MAB3422) followed a Tetramethyl
Rhodamine Isothiocyanate (TRITC)-conjugated secondary
antibody (Invitrogen Cat# T2762). DNA was counterstained with
Hoechst 33342 (AnaSpec Inc, Cat# 83218). Coverslips were
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mounted onto glass slides using Prolong Gold mounting media
(Invitrogen Cat# P36930) before acquisition.
Determination of neutrophil serine protease activity
Human neutrophil serine proteases were purchased from
Athens Research & Technology. A set of internally quenched
fluorescent substrates (40 µM each) were assayed with 20 nM
of NE (Cat# 16-14-051200), CG (Cat# 16-14-030107) and PR3
(Cat# 16-14-161820) in Dulbecco’s-PBS containing 0.01%
Tween-20 at room temperature. Triplicate assays were
performed in 96-well plates in a Spectra Max Gemini EM
(Molecular Devices) using a λex 328nm and λem 393 nm. Initial
velocities (relative fluorescent units/s) were calculated using
SoftMax Pro software (Molecular Devices). NET samples were
prepared as described above from three donors with the
following combinations: +PMA/+MNase, +PMA/-MNase, and –
PMA/+MNase treatment. 2 µg/ml of each NET sample was
assayed in triplicate with 40 µM of (K-Mca) PLGKQVEY(K-
Dnp). Initial velocities were converted to µmole/min/mg.
Peptide cleavage site identification by multiplex
substrate profiling-mass spectrometry
Recombinant NSP4 was expressed and isolated from HEK
293 cells as described previously [15]. NE (1 nM), CG (5 nM),
PR3 (2 nM) and NSP4 (25nM) were profiled using the MSP-MS
assay in Dulbecco’s-PBS as described previously [17]. In
addition, proteolytic activities in three PMA-induced and
MNase-treated donor NET samples were determined using the
MSP-MS assay. Control samples lacked PMA or MNase
treatment and consisted of an equal mixture of total protein
from each donor. All assays contained 0.4 µg/mL of donor
protein and 500 nM of each peptide in a total reaction volume
of 900 µl. Aliquots were removed after 15, 60, 240, and 1200
minutes and quenched with concentrated formic acid to a final
pH of 2.5. Samples were desalted and analyzed by LC-MSMS
peptide sequencing.
For LC-MS/MS, an LTQ-FT mass spectrometer (Thermo)
equipped with a 10,000 psi system nanoACUITY (Waters)
UPLC instrument was used for reversed phase
chromatography with a C18 column (BEH130, 1.7 µm bead
size, 100 µm x 100 mm). The LC was operated at 600 nL/min
flow rate, and peptides were separated using a linear gradient
over 42 min from 2% B to 30% B, with solvent A: 0.1% formic
acid in water and solvent B: 0.1% formic acid in 70%
acetonitrile. Survey scans were recorded over 350-1800 m/z
range, and MS/MS was performed with CID fragmentation on
the six most intense precursor ions. Mass spectrometry peak
lists were generated using in-house software called PAVA, and
data were searched using Protein Prospector software v.
5.10.0 [38]. Data was searched against a database containing
the sequences of the 124 14-mer synthetic peptides,
concatenated with 4 different copies of randomized sequences
for the same 124 entries to create a final database of 620
sequences for estimation of false discovery rate [39]. For
database searching, peptide sequences were matched with no
enzyme specificity requirement, and variable modifications
including oxidation of Trp, Pro and Phe, and N-terminal
pyroGlu from Gln. Protein Prospector score thresholds were
selected to be minimum protein score of 20, minimum peptide
score of 15, and maximum expectation values of 0.1 for
“protein” and 0.05 for peptide matches, and resulted in a
peptide false discovery rate of 0.2%. Cleavage site data was
extracted from Protein Prospector using an in house script
called “MSP extractor” software. The earliest time interval that
≥2.5% (n=41) of all possible bonds in the library (n = 1612)
were cleaved was chosen to compare enzymes specificity. NE,
PR3 and CG reached this value after 240, 1200 and 60
minutes incubation, respectively while NSP4 cleaved only 1.2%
(n=19) of peptide bonds after 1200 minutes. For comparison of
substrate specificity, an iceLogo software was used to generate
substrate specificity logos for amino acids at ±4 positions
adjacent to the identified cleavage sites [40].
Protein identification of NETs by mass spectrometry
Protein identification in NET-induced samples was performed
using peptide sequencing by mass spectrometry as previously
reported [17]. The +PMA/+MNase treated samples were
assayed individually for each donor, while the +PMA/-MNase,
and -PMA/+MNase control samples were prepared as pooled
mass-matched samples from the three donors. NET protein
concentrations ranged from 25-40 µg/ml in PBS, therefore a
slightly modified in solution trypsin digestion protocol was
applied as follows. Samples were brought to a standardized
concentration of 30 µg/ml with 100 mM ammonium bicarbonate
buffer (~20 µg in a total volume of 700 µl) to which solid urea
was added to 4M final. Sample was reduced with 10 mM DTT
incubation for 10 min at 56 °C, then alkylated with 12 mM
iodoacetamide (45 min, dark, 21 °C), and then quenched with 5
mM additional DTT. The final volume was adjusted to 1.4 ml
with additional 100 mM ammonium bicarbonate, bringing urea
concentration to 2M. Trypsin (sequencing grade, Promega)
was added at 1:50 trypsin: total protein for digestion overnight
at 37 °C. The sample was then acidified with formic acid to pH
2-3 and desalted using C18 OMIX tips (Varian). Each sample
was assayed with two technical replicate LC-MS/MS analyses
using an LTQ-Orbitrap (Thermo) mass spectrometer operated
under identical separation and analysis conditions as the LTQ-
FT system described above.
Database searches were performed against the H. sapiens
UniProt database (downloaded March 21, 2012), containing
62,611 entries. For estimation of false discovery rate, this
database was concatenated with a fully randomized set of
sequence entries [36]. Data were searched with mass
tolerances of 20 ppm for parent and 0.8 Da for fragment ions.
Peptide sequences were matched as tryptic peptides with no
missed cleavages, and carbamidomethylated cysteines as a
fixed modification. Variable modifications included oxidation of
Met, N-terminal pyroGlu from Gln, loss of Met and N-terminal
acetylation. Protein Prospector score parameters were:
minimum protein score of 22, minimum peptide score of 15,
and maximum expectation values of 0.01 for protein and 0.001
for peptide matches, resulting in a protein false discovery rate
of 1.1%. Protein identification results are reported with unique
peptide count, peptide count as an approximation of protein
abundance, percent sequence coverage and an expectation
value for the probability of the protein identification [38,39].
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Proteins were required to have been identified with at least two
unique peptides in one of the three conditions tested (+PMA/
+MNase, +PMA/-MNase, and -PMA/+MNase) to be reported.
Proteolytic activity using combinatorial fluorogenic
substrate libraries
Non-prime side sequence specificity, as the N-terminal
sequence relative to the scissile bond is termed in protease
nomenclature, was assayed for proteases using combinatorial
fluorogenic substrate libraries [19]. This fluorescent peptide
library is amenable for detailed profiling of purified serine
proteases and distinguishes between subsite preferences in
closely related enzymes. Human NE (50 nM), CG (100 nM),
PR3 (50 nM) and NSP4 (100 nM) were assayed with this
fluorogenic library in Dulbecco’s-PBS containing 0.01%
Tween-20. Amino acid preferences at each position can be
determined by direct comparison of activity, in units of
picomolar of fluorophore released per second.
Depletion of elastase from NET supernatants
MNase preparations of NET samples were secondarily
digested with DNase (100U/ml) for 10 minutes at 37° to fully
release NET-associated proteins. NET supernatants were then
mixed with Pierce G/A magnetic beads (Thermo Scientific, Cat#
88802) coated with elastase antibodies (Sigma, Cat#
PAI-74132) at 4 °C for 1 hour. After incubation, the
supernatants were separated from beads on a DYNAL-magnet
bead separation rack (Invitrogen Cat# 123-21D).
Supporting Information
Figure S1.  Screening of a set of internally quenched
fluorescent peptides to identify a substrate that can be
cleaved by NE (blue), PR3 (yellow) and CG (green). All
sequences have a N-terminal lysine(Mca) group and a C-
terminal lysine(Dnp).
(TIF)
Figure S2.  Substrate specificity of human neutrophil
serine proteases using the P4-P1 complete diverse
positional scanning synthetic combinatorial library. The x
axis indicated the amino acids held constant at each position
with “n” representing norleucine. All assays were performed in
triplicate and the y axis indicates fluorescence released per
second relative to the highest fluorescence observed for the
enzyme at a single fixed position.
(TIF)
Figure S3.  Determination of the proteolytic signatures in
NE-depleted NETs. A-C. IceLogos representing the P4 to P4′
sites for NE-depleted NETs isolated from three donor samples.
Amino acids that are most frequently observed (above axis)
and least frequently observed (below axis) are illustrated. The
numbers of cleavage sites used to make each iceLogo are
listed in the bottom right-hand corner. Residues that are
highlighted in black text are significantly (p = 0.05) enriched
relative to the frequency that these same amino acids are
found in the peptide library (5.2 +/- 0.5%). The amino acid ‘n’
corresponds to norleucine.
(TIF)
Table S1.  Comparison of NE, PR3 and NSP4 substrate
specificity using MSP-MS and PICS.
(DOCX)
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